Trial · NCT02741713
Analgesic Benefit of PECS Blocks for Biceps Tenodesis Shoulder Surgery
NCT02741713, Phase 3, Completed, Wake Forest University Health Sciences; results first posted 2018-08-27
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Analgesic Benefit of PECS Blocks for Biceps Tenodesis Shoulder Surgery. Trials, record NCT02741713. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02741713
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Analgesic Benefit of PECS Blocks for Biceps Tenodesis Shoulder Surgery
- NCT number
- NCT02741713
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 40 participants, actual
- Lead sponsor
- Wake Forest University Health Sciences
- Conditions
- Biceps Tendonitis
- Interventions
- PECS "Pectoralis" 1 and 2 Blocks, Interscalene Block, Sham Block, Solution for Injection in Interscalene Block, Solution for Injection in Sham Block, Solution for Injection PECS Blocks
- First posted
- 2016-04-18
- Last updated
- 2018-08-27
- Results first posted
- 2018-08-27
- Limitations and caveats
- Only 8 patients in the PECS group reported the onset of axillary pain at home, so that data set is very limited.
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Post-operative Axillary Pain | 6 hours post-block. | Post-operative ambulatory surgery subjects will be asked 6 hours after block placement about the presence of axillary pain at rest. Numerical Rating Scale scores (0-10) will be recorded with 0= no pain, 10=most pain possible. Higher scores denotes worse outcome. |
| Secondary | Numerical Rating Scale Pain Scores (0-10) at Rest | Assessed 24hrs post-block on a scale from 0-10. | Subjects were asked about their overall shoulder pain during the followup phone call at 24hrs post-block. Numerical Rating Scale scores (0-10) will be recorded with 0= no pain, 10=most pain possible. Higher scores denotes worse outcome. |
| Secondary | Percentage of Participants With Episodes of Nausea or Vomiting | Assessed 24hrs post-block (yes/no) | Any episodes during the first 24 hours will be recorded as a yes. |
| Secondary | Total Opioid Usage | Assessed 24hrs post-block in mg | Recorded in oxycodone equivalents in the first 24 hours post-discharge from the PACU. |
| Secondary | Time From Block Placement to Onset of Axillary Pain | Assessed 24hrs post-block in hours | Time self-reported by patients in the Interscalene Plus PECS Blocks group during data collection phone call at 24 hours post-block. |
Source ClinicalTrials.gov
Outcomes5
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Post-operative Axillary Pain | 6 hours post-block. | units on a scale | MEDIAN | |
| SECONDARY | Numerical Rating Scale Pain Scores (0-10) at Rest | Assessed 24hrs post-block on a scale from 0-10. | units on a scale | MEDIAN | |
| SECONDARY | Percentage of Participants With Episodes of Nausea or Vomiting | Assessed 24hrs post-block (yes/no) | percentage of participants | NUMBER | |
| SECONDARY | Total Opioid Usage | Assessed 24hrs post-block in mg | mg | MEAN | |
| SECONDARY | Time From Block Placement to Onset of Axillary Pain | Assessed 24hrs post-block in hours | This Outcome Measure was assessed only in the Interscalene Plus PECS Blocks group | Hours | MEAN |
Source ClinicalTrials.gov
Results by group9
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Post-operative Axillary Pain | Interscalene Block Plus Sham Block | 3 | Inter-Quartile Range 0 to 5.25 | units on a scale | |
| Post-operative Axillary Pain | Interscalene Plus PECS Blocks | 0 | Inter-Quartile Range 0 to 1.5 | units on a scale | |
| Numerical Rating Scale Pain Scores (0-10) at Rest | Interscalene Block Plus Sham Block | 6 | Inter-Quartile Range 5 to 7 | units on a scale | |
| Numerical Rating Scale Pain Scores (0-10) at Rest | Interscalene Plus PECS Blocks | 6 | Inter-Quartile Range 4 to 7 | units on a scale | |
| Percentage of Participants With Episodes of Nausea or Vomiting | Interscalene Block Plus Sham Block | 39 | percentage of participants | ||
| Percentage of Participants With Episodes of Nausea or Vomiting | Interscalene Plus PECS Blocks | 37 | percentage of participants | ||
| Total Opioid Usage | Interscalene Block Plus Sham Block | 31.6 | 95% Confidence Interval 24.1 to 39.0 | mg | |
| Total Opioid Usage | Interscalene Plus PECS Blocks | 26.9 | 95% Confidence Interval 21.8 to 32.0 | mg | |
| Time From Block Placement to Onset of Axillary Pain | Interscalene Plus PECS Blocks | 16.7 | 95% Confidence Interval 14.1 to 19.3 | Hours |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Interscalene Block Plus Sham Block | 20 | |
| Overall Study | STARTED | Interscalene Plus PECS Blocks | 20 | |
| Overall Study | COMPLETED | Interscalene Block Plus Sham Block | 18 | |
| Overall Study | COMPLETED | Interscalene Plus PECS Blocks | 19 | |
| Overall Study | NOT COMPLETED | Interscalene Block Plus Sham Block | 2 | |
| Overall Study | NOT COMPLETED | Interscalene Plus PECS Blocks | 1 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Interscalene Block Plus Sham Block | 0 | 18 |
| Total, all-cause mortality | Interscalene Plus PECS Blocks | 0 | 19 |
| Total, other adverse events | Interscalene Block Plus Sham Block | 0 | 18 |
| Total, other adverse events | Interscalene Plus PECS Blocks | 0 | 19 |
| Total, serious adverse events | Interscalene Block Plus Sham Block | 0 | 18 |
| Total, serious adverse events | Interscalene Plus PECS Blocks | 0 | 19 |
Source ClinicalTrials.gov
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 31136331 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Interscalene Block Plus Sham Block vs Interscalene Plus PECS Blocks: deaths from any cause | Trial comparisons |
| Interscalene Block Plus Sham Block vs Interscalene Plus PECS Blocks: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02741713
GET https://conductscience.org/api/trials/v1/NCT02741713/registered